|Title:||Oversight for clinical uses of autologous adult stem cells: lessons from international regulations|
|Keywords:||Autologous adult stem cells (ASCs)|
|Citation:||Lysaght T, Kerridge I, Sipp D, Porter G, Capps BJ. Oversight for clinical use of autologous adult stem cells: lessons from international regulations. Cell Stem Cell. 2013;13(6):647-51.|
|Abstract:||Autologous adult stem cells (ASCs) are being administered by physicians for indications that have not been demonstrated as safe and effective in formal clinical trials. Examination of regulatory frameworks across five countries suggests that balancing the demands of research with clinical freedom has created structural weaknesses that are being exploited.|
|Type of Work:||Article|
|Appears in Collections:||Research Papers and Publications. Sydney Health Ethics|
|oversight-for-clinical-uses-PP-2013.pdf||161.47 kB||Adobe PDF|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.